Xu Zi-Yao, Hao Xin-Yu, Wu Di, Song Qi-Ying, Wang Xin-Xin
Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
World J Gastrointest Surg. 2023 Jun 27;15(6):1093-1103. doi: 10.4240/wjgs.v15.i6.1093.
Preoperative evaluation of frailty is limited to a few surgical procedures. However, the evaluation in Chinese elderly gastric cancer (GC) patients remains blank.
To validate and estimate the prognostic value of the 11-index modified frailty index (mFI-11) for predicting postoperative anastomotic fistula, intensive care unit (ICU) admission, and long-term survival in elderly patients (over 65 years of age) undergoing radical GC.
This study was a retrospective cohort study which included patients who underwent elective gastrectomy with D2 Lymph node dissection between April 1, 2017 and April 1, 2019. The primary outcome was 1-year all-cause mortality. The secondary outcomes were admission to ICU, anastomotic fistula, and 6-mo mortality. Patients were divided into two groups according to the optimal grouping cutoff of 0.27 points from previous studies: High risk of frailty marked as mFI-11 and low risk of frailty marked as mFI-11. Survival curves between the two groups were compared, and univariate and multivariate regression analyses were performed to explore the relationship between preoperative frailty and postoperative complications in elderly patients undergoing radical GC. The discrimination ability of the mFI-11, prognostic nutritional index, and tumor-node-metastasis pathological stage to identify adverse postoperative outcomes was assessed by calculating the area under the receiver operating characteristic (ROC) curve.
A total of 1003 patients were included, of which 13.86% (139/1003) were defined as having mFI-11 and 86.14% (864/1003) as having mFI-11. By comparing the incidence of postoperative complications in the two groups of patients, it was found that mFI-11 patients had higher rates of 1-year postoperative mortality, admission to ICU, anastomotic fistula, and 6-mo mortality than the mFI-11 group (18.0% 8.9%, = 0.001; 31.7% 14.7%, < 0.001; 7.9% 2.8%, < 0.001; and 12.2% 3.6%, < 0.001). Multivariate analysis revealed mFI-11 as an independent predictive indicator for postoperative outcome [1-year postoperative mortality: Adjusted odds ratio (aOR) = 4.432, 95% confidence interval (95%CI): 2.599-6.343, = 0.003; admission to ICU: aOR = 2.058, 95%CI: 1.188-3.563, = 0.010; anastomotic fistula: aOR = 2.852, 95%CI: 1.357-5.994, = 0.006; 6-mo mortality: aOR = 2.438, 95%CI: 1.075-5.484, = 0.033]. mFI-11 showed better prognostic efficacy in predicting 1-year postoperative mortality [area under the ROC curve (AUROC): 0.731], admission to ICU (AUROC: 0.776), anastomotic fistula (AUROC: 0.877), and 6-mo mortality (AUROC: 0.759).
Frailty as measured by mFI-11 could provide prognostic information for 1-year postoperative mortality, admission to ICU, anastomotic fistula, and 6-mo mortality in patients over 65 years old undergoing radical GC.
术前对虚弱的评估仅限于少数外科手术。然而,中国老年胃癌(GC)患者的评估仍为空白。
验证并评估11指标改良虚弱指数(mFI-11)对老年(65岁以上)根治性GC患者术后吻合口瘘、入住重症监护病房(ICU)及长期生存的预后价值。
本研究为回顾性队列研究,纳入2017年4月1日至2019年4月1日期间接受选择性胃切除术并进行D2淋巴结清扫的患者。主要结局为1年全因死亡率。次要结局为入住ICU、吻合口瘘及6个月死亡率。根据既往研究中0.27分的最佳分组临界值将患者分为两组:mFI-11表示虚弱高风险,mFI-11表示虚弱低风险。比较两组之间的生存曲线,并进行单因素和多因素回归分析,以探讨老年根治性GC患者术前虚弱与术后并发症之间的关系。通过计算受试者操作特征(ROC)曲线下面积,评估mFI-11、预后营养指数和肿瘤-淋巴结-转移病理分期对识别术后不良结局的判别能力。
共纳入1003例患者,其中13.86%(139/1003)被定义为mFI-11,86.14%(864/1003)为mFI-11。通过比较两组患者术后并发症的发生率,发现mFI-11患者术后1年死亡率、入住ICU、吻合口瘘及6个月死亡率均高于mFI-11组(18.0%对8.9%,P = 0.001;31.7%对14.7%,P < 0.001;7.9%对2.8%,P < 0.001;12.2%对3.6%,P < 0.001)。多因素分析显示mFI-11是术后结局的独立预测指标[术后1年死亡率:调整优势比(aOR)= 4.432,95%置信区间(95%CI):2.599 - 6.343,P = 0.003;入住ICU:aOR = 2.058,95%CI:1.188 - 3.563,P = 0.010;吻合口瘘:aOR = 2.852,95%CI:1.357 - 5.994,P = 0.006;6个月死亡率:aOR = 2.438,95%CI:1.075 - 5.484,P = 0.033]。mFI-11在预测术后1年死亡率[ROC曲线下面积(AUROC):0.731]、入住ICU(AUROC:0.776)、吻合口瘘(AUROC:0.877)及6个月死亡率(AUROC:0.759)方面显示出更好的预后效果。
mFI-11所衡量的虚弱可为65岁以上接受根治性GC的患者术后1年死亡率、入住ICU、吻合口瘘及6个月死亡率提供预后信息。